Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 2

Sponsor Class

OTHER 191INDUSTRY 51OTHER_GOV 10UNKNOWN 3NIH 3NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 5Lymphoid 4Head & Neck 4Gastrointestinal 4Sarcoma 3Thoracic 2Other hematologic neoplasm 2Gynecologic 2CNS 2Genitourinary 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Ovarian Neoplasms 1

Interventions

Cisplatin 40Carboplatin 40Paclitaxel 34Radiotherapy 32Docetaxel 19Pemetrexed 17Gemcitabine 17Etoposide 17Bevacizumab 11Radiosurgery 9Magnetic Resonance Spectroscopy 9Ramucirumab 8durvalumab 7Taxes 7Cetuximab 7pembrolizumab 6Specimen Handling 6Erlotinib Hydrochloride 6Irinotecan 5Gene Expression Profiling 5Filgrastim 5cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Amplified Fragment Length Polymorphism Analysis 4tremelimumab 3osimertinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Drug Therapy × Thoracic × Clear all
NCT05633602 2026-04-17

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

SWOG Cancer Research Network

Phase 3 Active not recruiting
838 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03939481 2026-04-13

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

SWOG Cancer Research Network

Active not recruiting
1,336 enrolled
GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡